Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Apr;122(4):1191.
doi: 10.1172/jci62745.

Alzheimer’s disease: the new promise

Warren J Strittmatter  1
Affiliations
Comment

Alzheimer’s disease: the new promise

Warren J Strittmatter. J Clin Invest. 2012 Apr.

Abstract

Clinical vignette: A 59-year-old aeronautical engineer is referred to you for evaluation because of increasing difficulty with job performance over the last several years. Difficulty managing home finances, getting lost driving, and forgetting appointments have become common. Previously outgoing, he is now depressed and irritable. After appropriate neurologic assessment, including brain imaging and metabolic studies, you make the diagnosis of Alzheimer’s dementia and are asked by the patient’s family what treatment is available.

PubMed Disclaimer

Comment on

References

    1. Maurer K, Volk S, Gerbaldo H. Auguste D and Alz­heimer’s disease. Lancet. 1997;349(9064):1546–1549. doi: 10.1016/S0140-6736(96)10203-8. - DOI - PubMed
    1. Karran E, Mercken M, DeStrooper B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Dis. 2011;10(9):698–712. doi: 10.1038/nrd3505. - DOI - PubMed
    1. Sperling RA, Jack CR, Jr, Aisen PS. Testing the right target and the right drug at the right stage. Science Trans Med. 2011;3(111):111cm33. - PMC - PubMed
    1. Talbot K, et al. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122(4):1316–1338. doi: 10.1172/JCI59903. - DOI - PMC - PubMed
    1. Bomfim TR, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers. J Clin Invest. 2012;122(4):1339–1353. doi: 10.1172/JCI57256. - DOI - PMC - PubMed